+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Therapy Media, Cell Therapy Kits, Cell Therapy Reagents and Cell Therapy Surface Market: Distribution by Type of Product, Type of Cell Therapy, Scale of Operation, Type of End-User and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • PDF Icon

    Report

  • 300 Pages
  • March 2023
  • Region: Global
  • Roots Analysis
  • ID: 5749400

The therapeutic approach involving the injection of healthy cells in the human body to replace the diseased / non-functioning cells, in order to regulate certain functions, is referred to as cell therapy. In the past few years, this therapeutic approach has emerged as one of the key areas of interest in the healthcare sector, given its ability to treat diseases which were previously considered untreatable. Consequently, driven by the benefits offered by cellular therapies and recent approvals granted by regulatory authorities, the demand for cellular therapies has increased considerably; this has led to a rise in the requirement of cell therapy raw materials. Specifically, cell therapy consumables refer to materials that are used in cell therapy manufacturing. It is worth mentioning that the selection of cell therapy consumables, specifically the cell culture media and supplements, is a crucial step in cell therapy manufacturing as they directly impact the potency and safety of the final product. In this report, we have considered the four predominant types of consumables applicable to cell therapy, namely cell culture media, media kits providing culture media along with the necessary media supplements, reagents and extracellular matrices.

Key Market Insights

The Cell Therapy Media, Cell Therapy Kits, Cell Therapy Reagents and Cell Therapy Surface Market (2nd Edition): Distribution by Type of Product (Culture Media, Kits, Reagents and Extracellular Matrices), Type of Cell Therapy (T-Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy and NK Cell Therapy), Scale of Operation (Clinical and Commercial), Type of End-User (Industry and Non-Industry) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa (MENA) and Latin America): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape and the likely future potential of the cell culture media (supplied alone or in kits as a combination with cell growth supplements), cell culture reagents and ECM market, over the next 12 years. It highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry. Key inclusions of the report are briefly discussed below.

Growing Demand for Cell Therapies

Since the development of the first cell therapy, this therapeutic segment has garnered significant attention from researchers and medical practitioners. This can be attributed to the fact that cell therapies have been demonstrated to possess a vast potential in the treatment of rare disorders, which were previously considered incurable. The popularity of this therapeutic class of products can also be validated from the fact that, since 2019, more than 1,000 clinical trials focused on cell therapies have been initiated. It is also worth mentioning that over 35 cell and gene therapies have already been commercialized, across various geographical locations, till date. Notable examples of recently approved cell therapies include (in reverse chronological order) Breyanzi® (June 2022), Carvykti™ (February 2022) and Abecma® (March 2021).

Need for High-Quality Cell Therapy Consumables

Driven by the rise in popularity of cell therapies, there is a growth in demand for cell culture media, reagents and surfaces. It is worth mentioning that, amidst the increasing demand for such products, there is a rise in stringency from regulatory authorities to ensure that the quality of raw materials is good. Therefore, to meet the industry needs, cell therapy manufacturers are actively adopting serum free and xeno free products, which are known to reduce the risk of batch-to-batch variability.

Role of Consumables in Commercialization of Cell Therapies

Currently, the marketed cell-based therapies are exorbitantly priced. Even though, with the introduction of automation technologies in cell therapy bioprocessing, the cost and time required for development of such products has reduced significantly, there is still a considerable scope of improvement to make these therapies affordable. 

In this context, it is worth mentioning that consumables, including media, reagents and matrices, currently constitute nearly 25% of the overall cost of cell therapy manufacturing. Optimization of raw materials, by streamlining the production processes, can help mitigate wastage and further reduce the manufacturing cost. Moreover, for commercial applications, it is crucial to obtain consistent outcomes during the manufacturing process. Cell culture media, with chemically defined formulation, provides enhanced consistency for production purposes. 

Current Market Landscape of Cell Therapy Media, Kits, Reagents and Surfaces

The cell therapy consumable providers market landscape features more than 80 companies, which claim to possess the necessary expertise for manufacturing of over 450 research and / or therapeutic grade raw materials. Some of these players also claim to have developed GMP certified facilities for the production of consumables, which are intended to be used for a range of human cells, including T-cells, stem cells, dendritic cells and NK cells. Subsequently, cell therapy media market represents majority share (57%) of consumables offered, followed by the share captured by media and supplement kits (26%), extracellular matrices (14%) and cell culture reagents (3%). The ancillary materials offered by these companies are available in various volumes and can be utilized for numerous functions, such as cell proliferation, cell differentiation and cell isolation. Recent developments in this domain indicate that cell therapy consumable providers are actively expanding their capacity and product portfolio in order to accommodate the current and anticipated demand for cell therapies.

Recent Trends Related to Cell Culture Media

In recent years, there has been a considerable rise in regulatory stringency as well as awareness related to disadvantages of using animal-based medica formulations, in the cell therapy domain. Specifically, animal-based media pose an undesirable risk of transfecting infectious agents. This has resulted in a shift towards the higher adoption of chemically defined, animal-component free (serum-free and xeno-free) media, in the cell culture media market. It is worth mentioning that, currently, majority of the cell culture media are being used for the development of stem cell therapies, followed by those intended for T-cell therapies.

Key Drivers in the Cell Therapy Consumables Market

One of the key drivers of the investments in this market is the success of previously commercialized cell therapies. More than USD 35 billion has already invested in cell therapy domain by private investors. In the last few years, cell therapies have offered a relatively more reliable approach for the treatment of rare diseases. According to a study published in 2019, the prevalence rate of rare diseases is about 263 to 446 million individuals, at any point of time. This necessitates the need for more such life-saving therapies. It is worth highlighting that, by 2030, close to 60 cell and gene therapies are anticipated to receive regulatory approval, further expanding the opportunities associated within the market. These factors will, in turn, lead to a surge in the requirement for cell therapy consumables products, driving significant growth of the domain.

Market Size of the Cell Therapy Consumables Market

Driven by the indubitably rising need for cell therapies, the market for cell therapy media and other consumables is anticipated to grow at a CAGR of 12%, during the period 2023-2035. Specifically, in terms of scale of operation, the demand for consumable products for commercial operations are expected to expand rapidly with the anticipated approval of numerous cell therapies. Additionally, it is worth highlighting that more than 80% of the current market share is captured by players based in North America and Asia-Pacific. 

Example Players in the Cell Therapy Consumables Market

Examples of players engaged in this domain (which have also been captured in this report) include BD Biosciences, Bio-Techne, CellGenix, Corning, Irvine Scientific (Acquired by FUJIFILM), Lonza, Miltenyi Biotech, Sartorius, STEMCELL Technologies and Thermo Fisher Scientific.

Scope of the Report

The study presents an in-depth analysis of the various firms / organizations that are engaged in this domain, across different segments.

The report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different regions. Amongst other elements, the report includes:

  • An executive summary of the insights captured during our research, offering a high-level view on the current state of the cell therapy consumables market and its likely evolution in the mid-long term.
  • A general introduction to cell therapies, including details related to the development and manufacturing of such therapeutics products, with addition focus on role of raw materials in cell therapy production. It further provides a brief overview of the different types of cell therapy consumables and key challenges associated with their development. 
  • A detailed assessment of the overall market landscape of companies offering cell therapy consumables, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of product (kits, media, reagents and extracellular matrices), number and location of consumable facilities, accreditations received, type of end-user (industry and non-industry), media compatibility (serum free , xeno free and both), type of cell therapy (T-cell therapies, stem cell therapies, NK cell therapies, dendritic cell therapies and others), type of function (cell proliferation, cell expansion, cell differentiation, cell activation, cell isolation, cell attachment), kit components (supplements / reagents, growth / induction medium, expansion medium, differentiation medium and others), type of ECM coating (laminin, fibronectin, vitronectin, basement membrane extract and others), type of formulation (powder, liquid, pre-coated cultureware), shelf life (6-12 months, 13-18 months, 19-24 months and 25-36 months), scale of operation (discovery, preclinical, clinical and commercial), application area (research use and therapeutic use), storage temperature (refrigerated, frozen, ultra-low and room temperature), as well as volume of media, reagents and extracellular matrices. 
  • A detailed competitiveness analysis of cell therapy consumable providers (kits, media, reagents and extracellular matrices) based on supplier strength (in terms of years of experience and company size), portfolio strength (considering media compatibility, number of unique type of cell therapy, application area, product manufacturing practices and number of consumable facilities) and number of products offered. 
  • A detailed brand positioning analysis of prominent industry players (shortlisted on the basis of strength of service portfolio), highlighting the current perceptions regarding their proprietary brands across different consumable classes.
  • Elaborate profiles of key players offering cell therapy consumables (shortlisted on the basis of portfolio strength and number of products offered); each profile includes a brief overview of the company, along with information on its cell therapy consumables focused product portfolio, consumable facilities, recent developments and an informed future outlook. 
  • An analysis of recent developments within the cell therapy consumable industry, highlighting information on several partnerships and collaborations, mergers and acquisitions, and expansion initiatives that have taken place within this domain, during the period 2016-2022.
  • A list of over 250 cell therapy developers that are anticipated to partner with cell therapy consumable providers; these players have been shortlisted based on several relevant parameters, such as developer strength (which takes into account a company’s size and its experience in this field), pipeline strength and maturity (based on the number of pipeline drugs and affiliated stage of development), and availability of other cell therapy capabilities.
  • A proprietary competitive pricing framework, which analyzes the competitive position of various companies engaged in this domain, by taking into consideration the prices and features of their consumable offerings (such as media and extracellular matrices). In addition, it presents an equation devised to calculate the likely price of cell therapy consumables based upon their characteristics.
  • An informed estimate of the annual demand for cell therapy consumables (in terms of volume of media required for total number of cells), based on scale of operation and key geographical regions.
  • An in-depth discussion on the upcoming trends and future growth opportunities within the cell therapy consumables market, featuring details related to the significance of automation in cell therapy manufacturing processes and benefits of single use technologies for production of cell therapies.

One of the key objectives of the report was to estimate the current opportunity and the future growth potential of the cell therapy consumables market over the coming years. We have provided an informed estimate on the likely evolution of the market for the period, 2023-2035. Our year-wise projections of the current and forecasted opportunity have been further segmented based on relevant parameters, such as type of product (kits, media, reagents and extracellular matrices), type of cell therapy (t-cell therapies, stem cell therapies, dendritic cell therapies and NK cell therapies), scale of operation (clinical and commercial), type of end-user (industry and non-industry) and key geographical regions (North America, Europe, Asia-Pacific, MENA and Latin America). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic scenarios of the industry’s evolution.

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this domain.

The report features detailed transcripts of interviews held with the following individuals:

  • Anant Kamath (Chief Operating Officer, Cellular Engineering Technologies)
  • Vishal G. Warke (Director, R&D, Cell Culture and Immunology, HiMedia Laboratories) and Gauri W. Page (Assistant R&D Manager, Animal Cell Culture, HiMedia Laboratories)
  • Michael Maloney (Vice President, Business Development, Cell Culture, Akadeum Life Sciences)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Frequently Asked Questions

Question 1: What are the factors driving the cell therapy consumables market?

Answer: The growing demand for cell therapies, as a result of the increasing number of commercialized cell therapies and the rise in cell therapy focused clinical trials, is one of the key factors driving the growth of the cell therapy consumables market.

Question 2: How many players are engaged in offering cell culture media for manufacturing of cell therapies?

Answer: Currently, more than 65 companies claim to offer different types of cell culture media for the growth, proliferation, expansion and differentiation of numerous types of cell therapies.

Question 3: How many players are engaged in offering kits for manufacturing cell therapies?

Answer: At present, nearly 40 players claim to offer several types of kits required to manufacture cell therapies. These kits comprise of various key components, including supplements / reagents for isolation, activation and differentiation of cells, growth media, differentiation media and expansion media.

Question 4: How many media products are available in the market for culturing cell therapies?

Answer: The current market features the presence of nearly 260 media products, which can be used for the manufacturing of cell therapies intended for culturing of human cells.

Question 5: What are the partnership and collaboration trends in the cell therapy consumables domain?

Answer: At present, distribution agreements, mergers and acquisitions, and product commercialization agreements are the most common types of partnerships inked by stakeholders engaged in the cell therapy consumables domain. 

Question 6: Which geographical segment has the largest market share in the current cell therapy consumables market?

Answer: North America captures the largest share in the current cell therapy consumables market, followed by Asia-Pacific. It is worth mentioning that, within Asia-Pacific, majority of the market share is contributed by China.

Question 7: Which type of product contributes to the largest share of the cell therapy consumables market?

Answer: In 2023, the cell therapy consumables market is expected to be dominated by media. This trend can be attributed to the large quantity of media required for manufacturing of cell therapies.

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Context and Background
3.2. Introduction to Cell Therapies
3.3. Comparison of Cell Therapies with Other Biopharmaceuticals
3.4. Classification of Cell Therapy Products
3.5. Overview of Cell Therapy Development and Manufacturing
3.6. Role of Raw Materials in Cell Therapy Development and Manufacturing
3.7. Types of Cell Therapy Consumables
3.8. Key Challenges Associated with Manufacturing of Cell Therapy Consumables
3.9. Future Perspectives

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. List of Cell Therapy Kit Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Kit Manufacturing Facilities
4.2.5. Analysis by Certifications / Accreditations Received
4.2.6. Analysis by Type of End-User
4.2.7. Analysis by Type of Cell Therapy
4.2.8. Analysis by Type of Function
4.2.9. Analysis by Kit Components
4.2.10. Analysis by Storage Temperature
4.2.11. Analysis by Scale of Operation
4.2.12. Analysis by Application Area
4.2.13. Analysis by Application Area and Geography
4.3. List of Cell Therapy Media Providers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Location of Media Manufacturing Facilities
4.3.5. Analysis by Certifications / Accreditations Received
4.3.6. Analysis by Type of End-User
4.3.7. Analysis by Type of Cell Therapy
4.3.8. Analysis by Media Compatibility
4.3.9. Analysis by Type of Function
4.3.10. Analysis by Storage Temperature
4.3.11. Analysis by Volume of Media
4.3.12. Analysis by Scale of Operation
4.3.13. Analysis by Application Area
4.3.14. Analysis by Application Area and Geography
4.4. List of Cell Therapy Reagent Providers
4.4.1. Analysis by Year of Establishment
4.4.2. Analysis by Company Size
4.4.3. Analysis by Location of Headquarters
4.4.4. Analysis by Location of Reagent Manufacturing Facilities
4.4.5. Analysis by Certifications / Accreditations Received
4.4.6. Analysis by Type of End-User
4.4.7. Analysis by Type of Cell Therapy
4.4.8. Analysis by Type of Function
4.4.9. Analysis by Storage Temperature
4.4.10. Analysis by Volume of Reagent
4.4.11. Analysis by Scale of Operation
4.4.12. Analysis by Application Area
4.4.13. Analysis by Application Area and Geography
4.5. List of Cell Therapy Extracellular Matrix Providers
4.5.1. Analysis by Year of Establishment
4.5.2. Analysis by Company Size
4.5.3. Analysis by Location of Headquarters
4.5.4. Analysis by Location of Extracellular Matrix Manufacturing Facilities
4.5.5. Analysis by Certifications / Accreditations Received
4.5.6. Analysis by Type of End-User
4.5.7. Analysis by Type of Stem Cell Therapy
4.5.8. Analysis by Type of Function
4.5.9. Analysis by Type of ECM Coating
4.5.10. Analysis by Type of Formulation
4.5.11. Analysis by Shelf Life
4.5.12. Analysis by Storage Temperature
4.5.13. Analysis by Volume of Extracellular Matrix
4.5.14. Analysis by Scale of Operation
4.5.15. Analysis by Application Area
4.5.16. Analysis by Application Area and Geography

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Key Assumptions and Parameters
5.3. Methodology
5.4. Cell Therapy Consumable Providers: Company Competitiveness Analysis
5.5. Cell Therapy Kits Providers
5.6. Cell Therapy Media Providers
5.6.1. Cell Therapy Media Providers based in North America
5.6.2. Cell Therapy Media Providers based in Europe
5.6.3. Cell Therapy Media Providers based in Asia-Pacific
5.7. Cell Therapy Reagent Providers
5.8. Cell Therapy Extracellular Matrix Providers

6. BRAND POSITIONING OF KEY INDUSTRY PLAYERS
6.1. Chapter Overview
6.2. Scope and Methodology
6.3. Brand Positioning: STEMCELL Technologies
6.4. Brand Positioning: Miltenyi Biotec
6.5. Brand Positioning: Thermo Fisher Scientific
6.6. Brand Positioning: Takara Bio
6.7. Brand Positioning: GeminiBio

7. COMPANY PROFILES
7.1. Chapter Overview
7.2. STEMCELL Technologies
7.2.1. Company Overview
7.2.2. Product Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Miltenyi Biotec
7.3.1. Company Overview
7.3.2. Product Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. Thermo Fisher Scientific
7.4.1. Company Overview
7.4.2. Product Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. Bio-Techne
7.5.1. Company Overview
7.5.2. Product Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. Irvine Scientific
7.6.1. Company Overview
7.6.2. Product Portfolio
7.6.3. Recent Developments and Future Outlook
7.7. Lonza
7.7.1. Company Overview
7.7.2. Product Portfolio
7.7.3. Recent Developments and Future Outlook
7.8. Sartorius
7.8.1. Company Overview
7.8.2. Product Portfolio
7.8.3. Recent Developments and Future Outlook
7.9. BD Biosciences
7.9.1. Company Overview
7.9.2. Product Portfolio
7.9.3. Recent Developments and Future Outlook
7.10. Corning
7.10.1. Company Overview
7.10.2. Product Portfolio
7.10.3. Recent Developments and Future Outlook
7.11. CellGenix
7.11.1. Company Overview
7.11.2. Product Portfolio
7.11.3. Recent Developments and Future Outlook

8. RECENT DEVELOPMENTS AND INITIATIVES
8.1. Chapter Overview
8.2. Partnership Models
8.3. Cell Therapy Consumables: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Cell Therapy
8.3.7. Analysis by Type of Product and Type of Cell Therapy
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Region
8.3.9.1. Intercontinental and Intracontinental Agreements
8.3.9.2. Local and International Agreements
8.4. Cell Therapy Consumables: Mergers and Acquisitions
8.4.1. Cumulative Year-wise Trend of Mergers and Acquisitions
8.4.2. Analysis by Type of Agreement
8.4.3. Analysis by Key Value Drivers
8.4.4. Analysis by Year of Acquisition and Key Value Drivers
8.5. Cell Therapy Consumables: Recent Expansions
8.5.1. Analysis by Year of Expansion
8.5.2. Analysis by Type of Expansion
8.5.3. Analysis by Year and Type of Expansion
8.5.4. Analysis by Type of Product
8.5.5. Analysis by Type of Expansion and Type of Product
8.5.6. Analysis by Area of Expansion
8.5.7. Most Active Players: Analysis by Number of Expansions
8.5.8. Analysis by Region
8.5.8.1. Analysis by Location of Facility (Continent-wise)
8.5.8.2. Analysis by Location of Facility (Country-wise)
8.5.9. Analysis by Type of Expansion and Location of Facility

9. LIKELY PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS
9.1. Chapter Overview
9.2. Scoring Criteria and Key Assumptions
9.3. Scope and Methodology
9.4. Key Potential Strategic Partners for Cell Therapy Consumable Providers
9.4.1. Likely Partners for Dendritic Cell Therapy Consumable Providers
9.4.2. Likely Partners for NK Cell Therapy Consumable Providers
9.4.3. Likely Partners for Stem Cell Therapy Consumable Providers
9.4.4. Likely Partners for T-Cell Therapy Consumable Providers

10. PRICING STRATEGY
10.1. Chapter Overview
10.2. Publisher Framework
10.2.1. Theoretical Framework and Price Evaluation Hypothesis for Cell Therapy Media
10.2.1.1. Methodology
10.2.1.2. Results and Interpretation
10.2.1.2.1. Cell Therapy Media Price Evaluation Matrix: Information on Volume of Media
10.2.1.2.2. Cell Therapy Media Price Evaluation Matrix: Information on Media Compatibility
10.2.1.2.3. Cell Therapy Media Price Evaluation Matrix: Information on Type of Product Manufacturing Practices
10.2.1.2.4. Cell Therapy Media Price Evaluation Matrix: Information on Application Area
10.2.1.2.5. Cell Therapy Media Price Evaluation Matrix: Information on Storage Temperature
10.2.1.2.6. Cell Therapy Media Price Evaluation Matrix: Information on Type of Cell Therapy
10.2.1.2.7. Cell Therapy Media Price Evaluation Matrix: Information on Type of Function
10.2.2. Theoretical Framework and Price Evaluation Hypothesis of Cell Therapy Extracellular Matrices
10.2.2.1. Methodology
10.2.2.2. Results and Interpretation
10.2.2.2.1. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of ECM Coating
10.2.2.2.2. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Formulation
10.2.2.2.3. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Volume of Extracellular Matrices
10.2.2.2.4. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Storage Temperature
10.2.2.2.5. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Shelf Life
10.2.2.2.6. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Stem Cell Therapy
10.2.2.2.7. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Function

11. DEMAND ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Global Demand for Cell Therapy Consumables
11.3.1. Global Demand for Cell Therapy Consumables for Planar Processes
11.3.2. Global Demand for Cell Therapy Consumables for Suspension Processes
11.4. Analysis by Scale of Operation
11.5. Analysis by Geography

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Global Cell Therapy Consumables Market, 2023-2035
12.4. Cell Therapy Consumables Market: Analysis by Type of Product
12.4.1. Cell Therapy Consumables Market for Extracellular Matrices, 2023-2035
12.4.2. Cell Therapy Consumables Market for Kits, 2023-2035
12.4.3. Cell Therapy Consumables Market for Media, 2023-2035
12.4.4. Cell Therapy Consumables Market for Reagents, 2023-2035
12.5. Cell Therapy Consumables Market: Analysis by Type of Cell Therapy
12.5.1. Cell Therapy Consumables Market for Dendritic Cell Therapies, 2023-2035
12.5.2. Cell Therapy Consumables Market for NK Cell Therapies, 2023-2035
12.5.3. Cell Therapy Consumables Market for Stem Cell Therapies, 2023-2035
12.5.4. Cell Therapy Consumables Market for T-Cell Therapies, 2023-2035
12.6. Cell Therapy Consumables Market: Analysis by Scale of Operation
12.6.1. Cell Therapy Consumables Market for Clinical Operations, 2023-2035
12.6.2. Cell Therapy Consumables Market for Commercial Operations, 2023-2035
12.7. Cell Therapy Consumables Market: Analysis by Type of End-User
12.7.1. Cell Therapy Consumables Market for Industry Players, 2023-2035
12.7.2. Cell Therapy Consumables Market for Non-Industry Players, 2023-2035
12.8. Cell Therapy Consumables Market: Analysis by Geography
12.8.1. Cell Therapy Consumables Market in North America, 2023-2035
12.8.1.1. Cell Therapy Consumables Market in the US, 2023-2035
12.8.1.2. Cell Therapy Consumables Market in Canada, 2023-2035
12.8.1.3. Cell Therapy Consumables Market in Rest of North America, 2023-2035
12.8.2. Cell Therapy Consumables Market in Europe, 2023-2035
12.8.2.1. Cell Therapy Consumables Market in Spain, 2023-2035
12.8.2.2. Cell Therapy Consumables Market in France, 2023-2035
12.8.2.3. Cell Therapy Consumables Market in Germany, 2023-2035
12.8.2.4. Cell Therapy Consumables Market in Italy, 2023-2035
12.8.2.5. Cell Therapy Consumables Market in the Netherlands, 2023-2035
12.8.2.6. Cell Therapy Consumables Market in the UK, 2023-2035
12.8.2.7. Cell Therapy Consumables Market in Rest of Europe, 2023-2035
12.8.3. Cell Therapy Consumables Market in Asia-Pacific, 2023-2035
12.8.3.1. Cell Therapy Consumables Market in China, 2023-2035
12.8.3.2. Cell Therapy Consumables Market in Korea, 2023-2035
12.8.3.3. Cell Therapy Consumables Market in Rest of Asia-Pacific, 2023-2035
12.8.4. Cell Therapy Consumables Market in Middle East and North Africa, 2023-2035
12.8.5. Cell Therapy Consumables Market in Latin America, 2023-2035

13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES
13.1. Chapter Overview
13.2. Emerging Trends Related to Cell Culture Media
13.3. Automation of Cell Therapy Manufacturing Processes
13.4. Single Use Systems and Technologies in Cell Therapy Manufacturing

14. CONCLUDING REMARKS
15. INTERVIEW TRANSCRIPTS
15.1. Chapter Overview
15.2. Akadeum Life Sciences
15.2.1. Interview Transcript: Michael Maloney, Vice President of Business Development - Cell Therapy
15.3. Cellular Engineering Technologies
15.3.1. Interview Transcript: Anant Kamath, Chief Operating Officer
15.4. HiMedia Laboratories
15.4.1. Interview Transcript: Vishal G. Warke, Director R&D, Cell Culture and Immunology and Gauri W. Page, Assistant R&D Manager, Animal Cell Culture

16. APPENDIX I: TABULATED DATA17. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
List Of Figures
Figure 2.1 Executive Summary: Market Landscape
Figure 2.2 Executive Summary: Recent Developments and Initiatives
Figure 2.3 Executive Summary: Demand Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Types of Cell Therapy Consumables
Figure 4.1 Cell Therapy Consumables: Distribution by Type of Product
Figure 4.2 Cell Therapy Consumable Providers: Distribution by Company Size and Location of Headquarters
Figure 4.3 Cell Therapy Kit Providers: Distribution by Year of Establishment
Figure 4.4 Cell Therapy Kit Providers: Distribution by Company Size
Figure 4.5 Cell Therapy Kit Providers: Distribution by Location of Headquarters
Figure 4.6 Cell Therapy Kit Providers: Distribution by Location of Kit Manufacturing Facilities
Figure 4.7 Cell Therapy Kit Providers: Distribution by Certifications / Accreditations Received
Figure 4.8 Cell Therapy Kit Providers: Distribution by Type of End-User
Figure 4.9 Cell Therapy Kits: Distribution by Type of Cell Therapy
Figure 4.10 Cell Therapy Kits: Distribution by Type of Function
Figure 4.11 Cell Therapy Kits: Distribution by Kit Components
Figure 4.12 Cell Therapy Kits: Distribution by Storage Temperature
Figure 4.13 Cell Therapy Kits: Distribution by Scale of Operation
Figure 4.14 Cell Therapy Kits: Distribution by Application Area
Figure 4.15 Cell Therapy Kit Providers: Distribution by Application Area and Geography
Figure 4.16 Cell Therapy Media Providers: Distribution by Year of Establishment
Figure 4.17 Cell Therapy Media Providers: Distribution by Company Size
Figure 4.18 Cell Therapy Media Providers: Distribution by Location of Headquarters
Figure 4.19 Cell Therapy Media Providers: Distribution by Location of Media ManufacturingFacilities
Figure 4.20 Cell Therapy Media Providers: Distribution by Certifications / Accreditations Received
Figure 4.21 Cell Therapy Media Providers: Distribution by Type of End-User
Figure 4.22 Cell Therapy Media: Distribution by Type of Cell Therapy
Figure 4.23 Cell Therapy Media: Distribution by Media Compatibility
Figure 4.24 Cell Therapy Media: Distribution by Type of Function
Figure 4.25 Cell Therapy Media: Distribution by Storage Temperature
Figure 4.26 Cell Therapy Media: Distribution by Volume of Media
Figure 4.27 Cell Therapy Media: Distribution by Scale of Operation
Figure 4.28 Cell Therapy Media: Distribution by Application Area
Figure 4.29 Cell Therapy Media Providers: Distribution by Application Area and Geography
Figure 4.30 Cell Therapy Reagent Providers: Distribution by Year of Establishment
Figure 4.31 Cell Therapy Reagent Providers: Distribution by Company Size
Figure 4.32 Cell Therapy Reagent Providers: Distribution by Location of Headquarters
Figure 4.33 Cell Therapy Reagent Providers: Distribution by Location of Reagent Manufacturing Facilities
Figure 4.34 Cell Therapy Reagent Providers: Distribution by Certifications / Accreditations Received
Figure 4.35 Cell Therapy Reagent Providers: Distribution by Type of End-User
Figure 4.36 Cell Therapy Reagents: Distribution by Type of Cell Therapy
Figure 4.37 Cell Therapy Reagents: Distribution by Type of Function
Figure 4.38 Cell Therapy Reagents: Distribution by Storage Temperature
Figure 4.39 Cell Therapy Reagents: Distribution by Volume of Reagent
Figure 4.40 Cell Therapy Reagents: Distribution by Scale of Operation
Figure 4.41 Cell Therapy Reagents: Distribution by Application Area
Figure 4.42 Cell Therapy Reagent Providers: Distribution by Application Area and Geography
Figure 4.43 Cell Therapy Extracellular Matrix Providers: Distribution by Year of Establishment
Figure 4.44 Cell Therapy Extracellular Matrix Providers: Distribution by Company Size
Figure 4.45 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Headquarters
Figure 4.46 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Extracellular Matrix Manufacturing Facilities
Figure 4.47 Cell Therapy Extracellular Matrix Providers: Distribution by Certifications / Accreditations Received
Figure 4.48 Cell Therapy Extracellular Matrix Providers: Distribution by Type of End-User
Figure 4.49 Cell Therapy Extracellular Matrices: Distribution by Type of Stem Cell Therapy
Figure 4.50 Cell Therapy Extracellular Matrices: Distribution by Type of Function
Figure 4.51 Cell Therapy Extracellular Matrices: Distribution by Type of ECM Coating
Figure 4.52 Cell Therapy Extracellular Matrices: Distribution by Type of Formulation
Figure 4.53 Cell Therapy Extracellular Matrices: Distribution by Shelf Life
Figure 4.54 Cell Therapy Extracellular Matrices: Distribution by Storage Temperature
Figure 4.55 Cell Therapy Extracellular Matrices: Distribution by Volume of Extracellular Matrix
Figure 4.56 Cell Therapy Extracellular Matrices: Distribution by Scale of Operation
Figure 4.57 Cell Therapy Extracellular Matrices: Distribution by Application Area
Figure 4.58 Cell Therapy Extracellular Matrix Providers: Distribution by Application Area and Geography
Figure 5.1 Company Competitiveness Analysis: Cell Therapy Kit Providers
Figure 5.2 Company Competitiveness Analysis: Cell Therapy Media Providers based in North America
Figure 5.3 Company Competitiveness Analysis: Cell Therapy Media Providers based in Europe
Figure 5.4 Company Competitiveness Analysis: Cell Therapy Media Providers based in Asia-Pacific
Figure 5.5 Company Competitiveness Analysis: Cell Therapy Reagent Providers
Figure 5.6 Company Competitiveness Analysis: Cell Therapy Extracellular Matrix Providers
Figure 6.1 Brand Positioning Matrix: STEMCELL Technologies
Figure 6.2 Brand Positioning Matrix: Miltenyi Biotec
Figure 6.3 Brand Positioning Matrix: Thermo Fisher Scientific
Figure 6.4 Brand Positioning Matrix: Takara Bio
Figure 6.5 Brand Positioning Matrix: GeminiBio
Figure 7.1 STEMCELL Technologies: Product Portfolio
Figure 7.2 Miltenyi Biotec: Product Portfolio
Figure 7.3 Thermo Fisher Scientific: Product Portfolio
Figure 7.4 Bio-Techne: Product Portfolio
Figure 7.5 Irvine Scientific: Product Portfolio
Figure 7.6 Lonza: Product Portfolio
Figure 7.7 Sartorius: Product Portfolio
Figure 7.8 BD Biosciences: Product Portfolio
Figure 7.9 Corning: Product Portfolio
Figure 7.10 CellGenix: Product Portfolio
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2022
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 8.4 Partnerships and Collaborations: Distribution by Type of Product
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Consumable
Figure 8.6 Partnerships and Collaborations: Distribution by Type of Cell Therapy
Figure 8.7 Partnerships and Collaborations: Distribution by Type of Product and Type of Cell Therapy
Figure 8.8 Most Active Players: Distribution by Number of Partnerships
Figure 8.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 8.10 Partnerships and Collaborations: Local and International Agreements
Figure 8.11 Mergers and Acquisitions: Cumulative Year-wise Trend, 2016-2022
Figure 8.12 Mergers and Acquisitions: Distribution by Type of Agreement
Figure 8.13 Mergers and Acquisitions: Distribution by Key Value Drivers
Figure 8.14 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
Figure 8.15 Recent Expansions: Cumulative Year-wise Trend, 2017-2022
Figure 8.16 Recent Expansions: Distribution by Type of Expansion
Figure 8.17 Recent Expansions: Distribution by Year and Type of Expansion
Figure 8.18 Recent Expansions: Distribution by Type of Product
Figure 8.19 Recent Expansions: Distribution by Type of Expansion and Type of Consumable
Figure 8.20 Recent Expansions: Distribution by Area of Expansion (Sq. Ft.)
Figure 8.21 Most Active Players: Distribution by Number of Expansions
Figure 8.22 Recent Expansions: Distribution by Location of Facility (Continent-wise)
Figure 8.23 Recent Expansions: Distribution by Location of Facility (Country-wise)
Figure 8.24 Recent Expansions: Distribution by Type of Expansion and Location of Facility
Figure 10.1 Cell Therapy Media: Pricing Strategy Matrix
Figure 10.2 Cell Therapy Media: Pricing Strategy Graphical Interpretation
Figure 10.3 Cell Therapy Extracellular Matrices: Pricing Strategy Matrix
Figure 10.4 Cell Therapy Extracellular Matrices: Pricing Strategy Graphical Interpretation
Figure 11.1 Global Demand for Cell Therapy Consumables, 2023-2035 (Thousand Liters)
Figure 11.2 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035 (Thousand Liters)
Figure 11.3 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035 (Thousand Liters)
Figure 11.4 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Scale of Operation (Thousand Liters)
Figure 11.5 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Scale of Operation (Thousand Liters)
Figure 11.6 Global Demand for Cell Therapy Consumables: Distribution by Geography, 2023 and 2035
Figure 11.7 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Geography (Thousand Liters)
Figure 11.8 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Geography (Thousand Liters)
Figure 12.1 Global Cell Therapy Consumables Market, 2023-2035 (USD Million)
Figure 12.2 Cell Therapy Consumables Market: Distribution by Type of Product, 2023 and 2035
Figure 12.3 Cell Therapy Consumables Market for Extracellular Matrices, 2023-2035 (USD Million)
Figure 12.4 Cell Therapy Consumables Market for Kits, 2023-2035 (USD Million)
Figure 12.5 Cell Therapy Consumables Market for Media, 2023-2035 (USD Million)
Figure 12.6 Cell Therapy Consumables Market for Reagents, 2023-2035 (USD Million)
Figure 12.7 Cell Therapy Consumables Market: Distribution by Type of Cell Therapy, 2023, 2028 and 2035
Figure 12.8 Cell Therapy Consumables Market for Dendritic Cell Therapies, 2023-2035 (USD Million)
Figure 12.9 Cell Therapy Consumables Market for NK Cell Therapies, 2023-2035 (USD Million)
Figure 12.10 Cell Therapy Consumables Market for Stem Cell Therapies, 2023-2035 (USD Million)
Figure 12.11 Cell Therapy Consumables Market for T-Cell Therapies, 2023-2035 (USD Million)
Figure 12.12 Cell Therapy Consumables Market: Distribution by Scale of Operation, 2023 and 2035
Figure 12.13 Cell Therapy Consumables Market for Clinical Operations, 2023-2035 (USD Million)
Figure 12.14 Cell Therapy Consumables Market for Commercial Operations, 2023-2035 (USD Million)
Figure 12.15 Cell Therapy Consumables Market: Distribution by Type of End-User, 2023 and 2035
Figure 12.16 Cell Therapy Consumables Market for Industry Players, 2023-2035 (USD Million)
Figure 12.17 Cell Therapy Consumables Market for Non-Industry Players, 2023-2035 (USD Million)
Figure 12.18 Cell Therapy Consumables Market: Distribution by Geography, 2023 and 2035
Figure 12.19 Cell Therapy Consumables Market in North America, 2023-2035 (USD Million)
Figure 12.20 Cell Therapy Consumables Market in the US, 2023-2035 (USD Million)
Figure 12.21 Cell Therapy Consumables Market in Canada, 2023-2035 (USD Million)
Figure 12.22 Cell Therapy Consumables Market in Rest of North America, 2023-2035 (USD Million)
Figure 12.23 Cell Therapy Consumables Market in Europe, 2023-2035 (USD Million)
Figure 12.24 Cell Therapy Consumables Market in Spain, 2023-2035 (USD Million)
Figure 12.25 Cell Therapy Consumables Market in France, 2023-2035 (USD Million)
Figure 12.26 Cell Therapy Consumables Market in Germany, 2023-2035 (USD Million)
Figure 12.27 Cell Therapy Consumables Market in Italy, 2023-2035 (USD Million)
Figure 12.28 Cell Therapy Consumables Market in the Netherlands, 2023-2035 (USD Million)
Figure 12.29 Cell Therapy Consumables Market in the UK, 2023-2035 (USD Million)
Figure 12.30 Cell Therapy Consumables Market in Rest of Europe, 2023-2035 (USD Million)
Figure 12.31 Cell Therapy Consumables Market in Asia-Pacific, 2023-2035 (USD Million)
Figure 12.32 Cell Therapy Consumables Market in China, 2023-2035 (USD Million)
Figure 12.33 Cell Therapy Consumables Market in Korea, 2023-2035 (USD Million)
Figure 12.34 Cell Therapy Consumables Market in Rest of Asia-Pacific, 2023-2035 (USD Million)
Figure 12.35 Cell Therapy Consumables Market in Middle East and North Africa, 2023-2035 (USD Million)
Figure 12.36 Cell Therapy Consumables Market in Latin America, 2023-2035 (USD Million)
Figure 14.1 Concluding Remarks: Overall Market Landscape
Figure 14.2 Concluding Remarks: Recent Developments
Figure 14.3 Concluding Remarks: Demand Analysis
Figure 14.4 Concluding Remarks: Market Forecast and Opportunity Analysis
Figure 14.5 Concluding Remarks: Market Forecast and Opportunity Analysis

List Of Tables
Table 3.1 Cell Therapies: Applications
Table 3.2 Differences between Cell Therapies and Other Biopharmaceuticals
Table 3.3 Key Cell Therapy Manufacturing Steps
Table 3.4 Types of Media Used in Cell Therapy Manufacturing
Table 4.1 List of Cell Therapy Kit Providers
Table 4.2 Cell Therapy Kits: Information on Type of Cell Therapy and Type of Function
Table 4.3 Cell Therapy Kits: Information on Kit Components and Storage Temperature
Table 4.4 Cell Therapy Kits: Information on Scale of Operation and Application Area
Table 4.5 List of Cell Therapy Media Providers
Table 4.6 Cell Therapy Media: Information on Type of Cell Therapy, Media Compatibility and Type of Function
Table 4.7 Cell Therapy Media: Information on Storage Temperature and Volume of Media
Table 4.8 Cell Therapy Media: Information on Scale of Operation and Application Area
Table 4.9 List of Cell Therapy Reagent Providers
Table 4.10 Cell Therapy Reagents: Information on Type of Cell Therapy and Type of Function
Table 4.11 Cell Therapy Reagents: Information on Storage Temperature and Volume of Reagent
Table 4.12 Cell Therapy Reagents: Information on Scale of Operation and Application Area
Table 4.13 List of Cell Therapy Extracellular Matrix Providers
Table 4.14 Cell Therapy Extracellular Matrices: Information on Type of Stem Cell Therapy and Type of Function
Table 4.15 Cell Therapy Extracellular Matrices: Information on Type of ECM Coating and Type of Formulation
Table 4.16 Cell Therapy Extracellular Matrices: Information on Shelf Life, Storage Temperature and Volume of Extracellular Matrix
Table 4.17 Cell Therapy Extracellular Matrices: Information on Scale of Operation and Application Area
Table 7.1 STEMCELL Technologies: Company Overview
Table 7.2 STEMCELL Technologies: Recent Developments and Future Outlook
Table 7.3 Miltenyi Biotec: Company Overview
Table 7.4 Miltenyi Biotec: Recent Developments and Future Outlook
Table 7.5 Thermo Fisher Scientific: Company Overview
Table 7.6 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 7.7 Bio-Techne: Company Overview
Table 7.8 Bio-Techne: Recent Developments and Future Outlook
Table 7.9 Irvine Scientific: Company Overview
Table 7.10 Irvine Scientific: Recent Developments and Future Outlook
Table 7.11 Lonza: Company Overview
Table 7.12 Sartorius: Company Overview
Table 7.13 Sartorius: Recent Developments and Future Outlook
Table 7.14 BD Biosciences: Company Overview
Table 7.15 BD Biosciences: Recent Developments and Future Outlook
Table 7.16 Corning: Company Overview
Table 7.17 CellGenix: Company Overview
Table 7.18 CellGenix: Recent Developments and Future Outlook
Table 8.1 Cell Therapy Consumables: List of Partnerships and Collaborations, 2015-2022
Table 8.2 Cell Therapy Consumables: Information on Location of Headquarters, 2015-2022
Table 8.3 Mergers and Acquisitions: List of Mergers and Acquisitions, 2016-2022
Table 8.4 Mergers and Acquisitions: Information on Key Value Drivers, 2016-2022
Table 8.5 Cell Therapy Consumables: List of Recent Expansions, 2017-2022
Table 9.1 Key Potential Strategic Partners for Cell Therapy Consumable Providers
Table 9.2 Likely Partners for Dendritic Cell Therapy Consumable Providers
Table 9.3 Likely Partners for NK Cell Therapy Consumable Providers
Table 9.4 Likely Partners for Stem Cell Therapy Consumable Providers
Table 9.5 Likely Partners for T-Cell Therapy Consumable Providers
Table 10.1 Media Price Evaluation Matrix: Based on Volume of Media
Table 10.2 Media Price Evaluation Matrix: Based on Media Compatibility
Table 10.3 Media Price Evaluation Matrix: Based on Type of Product Manufacturing Practices
Table 10.4 Media Price Evaluation Matrix: Based on Application Area
Table 10.5 Media Price Evaluation Matrix: Based on Storage Temperature
Table 10.6 Media Price Evaluation Matrix: Based on Type of Cell Therapy
Table 10.7 Media Price Evaluation Matrix: Based on Type of Function
Table 10.8 ECM Price Evaluation Matrix: Based on Type of ECM Coating
Table 10.9 ECM Price Evaluation Matrix: Based on Type of Formulation
Table 10.10 ECM Price Evaluation Matrix: Based on Volume of Extracellular Matrix
Table 10.11 ECM Price Evaluation Matrix: Based on Storage Temperature
Table 10.12 ECM Price Evaluation Matrix: Based on Shelf Life
Table 10.13 ECM Price Evaluation Matrix: Based on Type of Stem Cell Therapy
Table 10.14 ECM Price Evaluation Matrix: Based on Type of Function
Table 15.1 Akadeum Life Sciences: Key Highlights
Table 15.2 Cellular Engineering Technologies: Key Highlights
Table 15.3 HiMedia Laboratories: Key Highlights
Table 16.1 Cell Therapy Consumables: Distribution by Type of Product
Table 16.2 Cell Therapy Consumable Providers: Distribution by Company Size and Location of Headquarters
Table 16.3 Cell Therapy Kit Providers: Distribution by Year of Establishment
Table 16.4 Cell Therapy Kit Providers: Distribution by Company Size
Table 16.5 Cell Therapy Kit Providers: Distribution by Location of Headquarters
Table 16.6 Cell Therapy Kit Providers: Distribution by Location of Kit Manufacturing Facilities
Table 16.7 Cell Therapy Kit Providers: Distribution by Certifications / Accreditations Received
Table 16.8 Cell Therapy Kit Providers: Distribution by Type of End-User
Table 16.9 Cell Therapy Kits: Distribution by Type of Cell Therapy
Table 16.10 Cell Therapy Kits: Distribution by Type of Function
Table 16.11 Cell Therapy Kits: Distribution by Kit Components
Table 16.12 Cell Therapy Kits: Distribution by Storage Temperature
Table 16.13 Cell Therapy Kits: Distribution by Scale of Operation
Table 16.14 Cell Therapy Kits: Distribution by Application Area
Table 16.15 Cell Therapy Media Providers: Distribution by Year of Establishment
Table 16.16 Cell Therapy Media Providers: Distribution by Company Size
Table 16.17 Cell Therapy Media Providers: Distribution by Location of Headquarters
Table 16.18 Cell Therapy Media Providers: Distribution by Location of Media Manufacturing Facilities
Table 16.19 Cell Therapy Media Providers: Distribution by Certifications / Accreditations Received
Table 16.20 Cell Therapy Media Providers: Distribution by Type of End-User
Table 16.21 Cell Therapy Media: Distribution by Type of Cell Therapy
Table 16.22 Cell Therapy Media: Distribution by Media Compatibility
Table 16.23 Cell Therapy Media: Distribution by Type of Function
Table 16.24 Cell Therapy Media: Distribution by Storage Temperature
Table 16.25 Cell Therapy Media: Distribution by Volume of Media
Table 16.26 Cell Therapy Media: Distribution by Scale of Operation
Table 16.27 Cell Therapy Media: Distribution by Application Area
Table 16.28 Cell Therapy Reagent Providers: Distribution by Year of Establishment
Table 16.29 Cell Therapy Reagent Providers: Distribution by Company Size
Table 16.30 Cell Therapy Reagent Providers: Distribution by Location of Headquarters
Table 16.31 Cell Therapy Reagent Providers: Distribution by Location of Reagent Manufacturing Facilities
Table 16.32 Cell Therapy Reagent Providers: Distribution by Certifications / Accreditations Received
Table 16.33 Cell Therapy Reagent Providers: Distribution by Type of End-User
Table 16.34 Cell Therapy Reagents: Distribution by Type of Cell Therapy
Table 16.35 Cell Therapy Reagents: Distribution by Type of Function
Table 16.36 Cell Therapy Reagents: Distribution by Storage Temperature
Table 16.37 Cell Therapy Reagents: Distribution by Volume of Reagent
Table 16.38 Cell Therapy Reagents: Distribution by Scale of Operation
Table 16.39 Cell Therapy Reagents: Distribution by Application Area
Table 16.40 Cell Therapy Extracellular Matrix Providers: Distribution by Year of Establishment
Table 16.41 Cell Therapy Extracellular Matrix Providers: Distribution by Company Size
Table 16.42 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Headquarters
Table 16.43 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Extracellular Matrix Manufacturing Facilities
Table 16.44 Cell Therapy Extracellular Matrix Providers: Distribution by Certifications / Accreditations Received
Table 16.45 Cell Therapy Extracellular Matrix Providers: Distribution by Type of End-User
Table 16.46 Cell Therapy Extracellular Matrices: Distribution by Type of Stem Cell Therapy
Table 16.47 Cell Therapy Extracellular Matrices: Distribution by Type of Function
Table 16.48 Cell Therapy Extracellular Matrices: Distribution by Type of ECM Coating
Table 16.49 Cell Therapy Extracellular Matrices: Distribution by Type of Formulation
Table 16.50 Cell Therapy Extracellular Matrices: Distribution by Shelf Life
Table 16.51 Cell Therapy Extracellular Matrices: Distribution by Storage Temperature
Table 16.52 Cell Therapy Extracellular Matrices: Distribution by Volume of Extracellular Matrix
Table 16.53 Cell Therapy Extracellular Matrices: Distribution by Scale of Operation
Table 16.54 Cell Therapy Extracellular Matrices: Distribution by Application Area
Table 16.55 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2022
Table 16.56 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.57 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership, 2015-2022
Table 16.58 Partnerships and Collaborations: Distribution by Type of Product
Table 16.59 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Consumable
Table 16.60 Partnerships and Collaborations: Distribution by Type of Cell Therapy
Table 16.61 Partnerships and Collaborations: Distribution by Type of Product and Type of Cell Therapy
Table 16.62 Most Active Players: Distribution by Number of Partnerships
Table 16.63 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 16.64 Partnerships and Collaborations: Local and International Agreements
Table 16.65 Mergers and Acquisitions: Cumulative Year-wise Trend, 2016-2022
Table 16.66 Mergers and Acquisitions: Distribution by Type of Agreement
Table 16.67 Mergers and Acquisitions: Distribution by Key Value Drivers
Table 16.68 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers, 2016-2022
Table 16.69 Recent Expansions: Cumulative Year-wise Trend, 2017-2022
Table 16.70 Recent Expansions: Distribution by Type of Expansion
Table 16.71 Recent Expansions: Distribution by Year and Type of Expansion, 2017-2022
Table 16.72 Recent Expansions: Distribution by Type of Product
Table 16.73 Recent Expansions: Distribution by Type of Expansion and Type of Product
Table 16.74 Recent Expansions: Distribution by Area of Expansion
Table 16.75 Most Active Players: Distribution by Number of Expansions
Table 16.76 Recent Expansions: Distribution by Location of Facility (Continent-wise)
Table 16.77 Recent Expansions: Distribution by Location of Facility (Country-wise)
Table 16.78 Recent Expansions: Distribution by Type of Expansion and Location of Facility
Table 16.79 Global Demand for Cell Therapy Consumables, 2023-2035 (Thousand Liters)
Table 16.80 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035 (Thousand Liters)
Table 16.81 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035 (Thousand Liters)
Table 16.82 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Scale of Operation (Thousand Liters)
Table 16.83 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Scale of Operation (Thousand Liters)
Table 16.84 Global Demand for Cell Therapy Consumables: Distribution by Geography, 2023 and 2035
Table 16.85 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Geography (Thousand Liters)
Table 16.86 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Geography (Thousand Liters)
Table 16.87 Global Cell Therapy Consumables Market, 2023-2035 (USD Million)
Table 16.88 Cell Therapy Consumables Market: Distribution by Type of Product, 2023 and 2035
Table 16.89 Cell Therapy Consumables Market for Extracellular Matrices, 2023-2035 (USD Million)
Table 16.90 Cell Therapy Consumables Market for Kits, 2023-2035 (USD Million)
Table 16.91 Cell Therapy Consumables Market for Media, 2023-2035 (USD Million)
Table 16.92 Cell Therapy Consumables Market for Reagents, 2023-2035 (USD Million)
Table 16.93 Cell Therapy Consumables Market: Distribution by Type of Cell Therapy, 2023, 2028 and 2035
Table 16.94 Cell Therapy Consumables Market for Dendritic Cell Therapies, 2023-2035 (USD Million)
Table 16.95 Cell Therapy Consumables Market for NK Cell Therapies, 2023-2035 (USD Million)
Table 16.96 Cell Therapy Consumables Market for Stem Cell Therapies, 2023-2035 (USD Million)
Table 16.97 Cell Therapy Consumables Market for T-Cell Therapies, 2023-2035 (USD Million)
Table 16.98 Cell Therapy Consumables Market: Distribution by Scale of Operation, 2023 and 2035
Table 16.99 Cell Therapy Consumables Market for Clinical Operations, 2023-2035 (USD Million)
Table 16.100 Cell Therapy Consumables Market for Commercial Operations, 2023-2035 (USD Million)
Table 16.101 Cell Therapy Consumables Market: Distribution by Type of End-User, 2023 and 2035
Table 16.102 Cell Therapy Consumables Market for Industry Players, 2023-2035 (USD Million)
Table 16.103 Cell Therapy Consumables Market for Non-Industry Players, 2023-2035 (USD Million)
Table 16.104 Cell Therapy Consumables Market: Distribution by Geography, 2023 and 2035
Table 16.105 Cell Therapy Consumables Market in North America, 2023-2035 (USD Million)
Table 16.106 Cell Therapy Consumables Market in the US, 2023-2035 (USD Million)
Table 16.107 Cell Therapy Consumables Market in Canada, 2023-2035 (USD Million)
Table 16.108 Cell Therapy Consumables Market in Rest of North America, 2023-2035 (USD Million)
Table 16.109 Cell Therapy Consumables Market in Europe, 2023-2035 (USD Million)
Table 16.110 Cell Therapy Consumables Market in Spain, 2023-2035 (USD Million)
Table 16.111 Cell Therapy Consumables Market in France, 2023-2035 (USD Million)
Table 16.112 Cell Therapy Consumables Market in Germany, 2023-2035 (USD Million)
Table 16.113 Cell Therapy Consumables Market in Italy, 2023-2035 (USD Million)
Table 16.114 Cell Therapy Consumables Market in the Netherlands, 2023-2035 (USD Million)
Table 16.115 Cell Therapy Consumables Market in the UK, 2023-2035 (USD Million)
Table 16.116 Cell Therapy Consumables Market in Rest of Europe, 2023-2035 (USD Million)
Table 16.117 Cell Therapy Consumables Market in Asia-Pacific, 2023-2035 (USD Million)
Table 16.118 Cell Therapy Consumables Market in China, 2023-2035 (USD Million)
Table 16.119 Cell Therapy Consumables Market in Korea, 2023-2035 (USD Million)
Table 16.120 Cell Therapy Consumables Market in Rest of Asia-Pacific, 2023-2035 (USD Million)
Table 16.121 Cell Therapy Consumables Market in Middle East and North Africa, 2023-2035 (USD Million)
Table 16.122 Cell Therapy Consumables Market in Latin America, 2023-2035 (USD Million)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Accellta
  • Acer Therapeutics
  • ACROBiosystems
  • Activartis Biotech
  • AddLife
  • Adicet Bio
  • Aduro Biotech
  • Advanced BioMatrix (Acquired by BICO)
  • Advent Bioservices
  • AGC Biologics
  • AgenTus Therapeutics
  • Agilent Technologies
  • Ajinomoto
  • Akadeum Life Sciences
  • Akron Biotech
  • Allele Biotechnology and Pharmaceuticals
  • Allife Medical Science and Technology
  • Allogene Therapeutics
  • Altor BioScience
  • American CryoStem
  • Amphera
  • AMSBIO
  • ANI Pharmaceuticals
  • apceth Biopharma
  • Applied Biological Materials
  • Applied Cells
  • Arbele
  • Arcline Investment Management
  • Argos Therapeutics
  • Aspire Health Science
  • Asterias Biotherapeutics
  • ATCC
  • Athersys
  • Atlantis Bioscience
  • Atreca
  • Aurora Biopharma
  • Austrianova
  • Autolus
  • Avantor
  • AVAX Technologies
  • Axion BioSystems
  • Axol Bioscience
  • Basic Pharma
  • BD Biosciences
  • Beijing Biohealthcare Biotechnology
  • Beijing Doing Biomedical
  • Beijing Immunochina Medical Science & Technology
  • Beijing Sanwater Biological Technology
  • Beijing Tricision Biotherapeutics 
  • Bellicum Pharmaceuticals
  • Bio Elpida
  • BioAtla
  • BioCardia
  • BioCare
  • BioCentriq
  • Bio-Connect
  • BioInno Bioscience
  • Bioinova
  • Biological Industries
  • BioRestorative Therapies
  • Bio-Techne 
  • Biowest
  • Bone Therapeutics
  • BrainStorm Cell Therapeutics
  • Brigham and Women’s Hospital
  • C3i (Center of Excellence for Cellular Therapy)
  • Caladrius Biosciences
  • Capricor Therapeutics
  • Captain T Cell
  • Captivate Bio
  • CardioCell
  • Carina Biotech
  • CARsgen Therapeutics
  • CAR-T (Shanghai) Biotechnology
  • Cartherics
  • Celixir
  • Cell and Gene Therapy Catapult
  • Cell Applications
  • Cell Biologics
  • Cell Biotech
  • Cell Culture Technologies
  • Cell Systems
  • Cell Therapies
  • Cell-Easy
  • Cellectis
  • CellGenix
  • Cellin Technologies
  • Cellmed
  • CellMP (A subsidiary of Emmecell)
  • CELLnTEC Advanced Cell Systems
  • CellPraxis
  • CellProtect Nordic Pharmaceuticals
  • CellProthera
  • Cells for Cells 
  • Cells Online
  • CellSystems
  • Cellular Biomedicine Group
  • Cellular Engineering Technologies
  • Cellular Therapeutics
  • Celprogen
  • Celularity
  • Celyad
  • Censo Biotechnologies
  • CHA Biolab
  • Chengdu MedGenCell
  • CiMaas
  • Cincinnati Children’s Hospital Medical Center
  • Clean Cells
  • CO.DON
  • Cogent Biosciences
  • Cognate BioServices
  • CoImmune
  • CollPlant
  • Cook MyoSite
  • Corestem
  • Corning
  • Creative Bioarray
  • Creative Biolabs
  • CRISPR Therapeutics
  • Cyagen
  • Cytiva
  • Cytopeutics
  • CytoSen Therapeutics (Acquired by Kiadis Pharma)
  • Cytovac
  • CyTuVax 
  • DanDrit Biotech
  • DCPrime
  • Delta-Vir
  • denovoMATRIX
  • DiscGenics
  • ElevateBio
  • Endocyte
  • Eureka Therapeutics
  • Eutilex
  • EXUMA Biotech
  • Fate Therapeutics
  • Fibrocell Technologies
  • Five Prime Therapeutics
  • Formula Pharmaceuticals
  • Fortress Biotech
  • Froceth
  • FroggaBio
  • FUJIFILM Cellular Dynamics
  • FUJIFILM Wako Pure Chemicals
  • Gadeta
  • Gamida Cell
  • GE Healthcare
  • GeminiBio
  • GenCure
  • GenCure (A subsidiary of BioBridge Global)
  • GenIbet Biopharmaceuticals
  • GigaGen 
  • Global Cell Med
  • Glycostem Therapeutics
  • Gradalis
  • GRI Bio
  • Guangzhou Trinomab Biotech
  • Heat Biologics
  • Hebei Senlang Biotechnology
  • Hemostemix
  • HengRui YuanZheng Bio-Technology
  • HiMedia Laboratories
  • Histocell
  • Histogenics
  • Hitachi Chemical
  • Holostem Terapie Avanzate
  • Hunan Zhaotai Yongren Biotech
  • IBA Lifesciences
  • iCarTAB BioMed
  • iCell Gene Therapeutics
  • Immatics
  • Immune Therapeutics
  • Immunicum
  • ImmunoCellular Therapeutics
  • Immunovative Therapies 
  • Immutep
  • IncoCell Tianjin (A subsidiary of Boyalife)
  • Incysus
  • Innoprot
  • Innovative Cellular Therapeutics
  • inRegen
  • International Stem Cell Corporation
  • InVitria
  • Iovance Biotherapeutics
  • Irvine Scientific (Acquired by FUJIFILM)
  • ISTO Technologies
  • Ivy Life Sciences
  • iXCells Biotechnologies
  • Japan Tissue Engineering
  • JSR 
  • JW Biotechnology
  • JW CreaGene
  • Kadimastem
  • Kangstem Biotech
  • Kiadis Pharma
  • Kiromic
  • Kuur Therapeutics
  • LAgen Laboratories
  • Laurus Labs
  • Laurus Bio
  • Leucid Bio
  • Life Technologies
  • Lifecells
  • Lifeline Cell Technology
  • Lineage Cell Therapeutics
  • Lion TCR
  • Living Pharma
  • Longeveron
  • Lonza
  • Lumos Pharma
  • Lyell Immunopharma
  • Lykan Bioscience
  • Marino Biotechnology
  • Matrixome
  • MaxCyte
  • MBL Beijing Biotech
  • Medeor Therapeutics
  • MEDianus Pharma
  • Medigene
  • MEDINET
  • MedVax Technologies
  • Mesoblast
  • Metrion Biosciences
  • Miltenyi Biotech
  • Minerva Biotechnologies
  • Minovia Therapeutics
  • MolecuVax
  • Moraga Biotechnology
  • MultiClonal Therapeutics
  • Multimmune
  • Multus Biotechnology
  • Mustang Bio 
  • Nanjing KAEDI Biotechnology
  • NantKwest
  • NeuCyte
  • Neuralstem
  • Neuromics
  • Nikon CeLL innovation
  • Nkarta
  • Nohla Therapeutics
  • Noile-Immune Biotech
  • Northern Therapeutics
  • Northwest Biotherapeutics
  • Novadip Biosciences
  • NovaRx (Acquired by Viropro)
  • Novex Innovations
  • Nucleus Biologics
  • Nuo Therapeutics
  • Octapharma
  • OiDE BetaRevive
  • Ology Bioservices
  • Omni Lifesciences
  • Oncobiomed
  • Opexa Therapeutics
  • Orchard Therapeutics
  • OrganaBio
  • Ori Biotech
  • Pall Corporation
  • PAN-Biotech
  • PBS Biotech
  • PDC*line Pharma
  • PELOBiotech
  • PeproTech
  • PersonGen BioTherapeutics
  • PharmaBio
  • Pharmicell
  • PhoenixSongs Biologicals
  • Pinze Lifetechnology
  • Pique Therapeutics
  • Pluristem Therapeutics
  • Plus Therapeutics
  • Poseida Therapeutics
  • Precision BioSciences
  • Preferred Cell Systems™
  • Pregene ShenZhen Biotechnology
  • Primorigen Biosciences (Acquired by Nucleus Biologics)
  • ProMab Biotechnologies
  • Promethera Biosciences
  • PromoCell
  • Propagenix
  • Provia Laboratories
  • R&D Systems
  • ReachBio Research Labs
  • Regeneris Medical
  • Regeneus
  • ReNeuron
  • REPROCELL
  • Rexgenero
  • RHEACELL
  • Riyadh Pharma
  • ROKIT Healthcare
  • RoosterBio
  • Roslin Cell Therapies
  • Rousselot Biomedical
  • Rubius Therapeutics
  • S.Biomedics
  • Sangamo Therapeutics
  • Sanvitra
  • Saronic Biotechnology
  • Sartorius
  • Sartorius Korea Biotech (A subsidiary of Sartorius)
  • Sartorius Stedim Biotech
  • ScienCell Research Laboratories
  • Scinogy
  • Sclnow Biotechnology
  • SCM Lifescience
  • Sentien Biotechnologies
  • Shanghai Bioray Laboratory
  • Shanghai Houchao Biotechnology
  • Shanghai iCELL Biotechnology
  • Shanghai Longyao Biotechnology
  • Shanghai Unicar-Therapy Bio-medicine Technology
  • Shenzhen BinDeBio
  • Shenzhen Hornetcorn Biotechnology
  • Sigma-Aldrich
  • Sinobioway Cell Therapy
  • SMT Bio
  • Sorrento Therapeutics
  • SQZ Biotechnologies
  • Stem Cell Arabia
  • STEMCELL Technologies
  • StemImmune
  • Stemmatters 
  • Super-T Cell Cancer Company
  • Surface Oncology
  • Tactiva Therapeutics
  • Taiwan Bio Therapeutics
  • Takara Bio
  • TapImmune 
  • Targazyme
  • TC BioPharm
  • TCR2 Therapeutics
  • Tella
  • Tessa Therapeutics
  • The Discovery Labs Center for Breakthrough Medicines
  • Thermo Fisher Scientific
  • ThermoGenesis
  • Tianhe Stem Cell Biotechnologies
  • Tianjin Ever Union Biotechnology 
  • TiGenix
  • TILT Biotherapeutics
  • Tmunity Therapeutics
  • TNK Therapeutics
  • TotipotentRX
  • TRACT Therapeutics
  • TransCure BioServices
  • TransGen Biotech
  • TreeFrog Therapeutics
  • TRINOVA BIOCHEM
  • Triumvira Immunologics
  • TVAX Biomedical
  • U.S. Stem Cell
  • United States Biological
  • Universal Cells
  • Vaccinogen
  • Vericel
  • VetStem Biopharma
  • Vinasets
  • ViroMed
  • Viscofan BioEngineering
  • Vitro Biopharma
  • Vivo Bio Tech
  • Waisman Biomanufacturing
  • West Biotherapy
  • WiCell
  • Wissenschaftlicher Service Pharma (WiSP)
  • Worchester Polytechnic Institute
  • Wuhan Sian Medical Technology
  • Xcell Therapeutics
  • Xcelthera
  • XEME Biopharma
  • ZellBio
  • Zelluna Immunotherapy
  • Ziopharm Oncology

Methodology

 

 

Loading
LOADING...